GSK’s linerixibat is currently under regulatory review in the US, Europe, and China, amongst other regions.

The deal also calls for the construction of a new facility at focused on engineering called the McLaren GSK Centre for Applied Performance. The facility will be built at McLaren’s headquarters outside ...

This acquisition comes as GSK looks to stock up its pipeline amid the looming patent expiries soon to impact the company’s portfolio.

This deal adds two more siRNA candidates to GSK’s pipeline, which the company is looking to expand as it looks to offset the impacts of key patent expiries within its portfolio.

New agreement supersedes the collaboration agreement entered in 2012 GSK retains non-exclusive right to use PRINT for pre-clinical research for inhaled delivery Liquidia (LQDA) can apply PRINT to any ...

GSK’s 35Pharma acquisition prioritizes HS235 within a projected $18B pulmonary hypertension market, where activin-pathway agents may capture roughly half of future value. Molecular selectivity ...

Aureus Pharma has announced that GlaxoSmithKline (GSK) has signed a multi-year license for Aureus Pharma’s AurSCOPE Knowledge databases. Researchers at GSK’s global research and development centers ...

Settlement reached over mRNA-based COVID vaccines CureVac and GSK get $740 million upfront, and royalties BioNTech's deal to buy CureVac on track GSK's own lawsuits against Pfizer, BioNTech unaffected ...

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today a collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline (GSK) to ...

GlaxoSmithKline has made a hire signaling its commitment to digital health. Karenann Terrell, former Chief Information Officer at Walmart, will start at GSK in the newly created role of Chief Digital ...